First Tracks Biotherapeutics Inc <TRAX.O>: Wedbush Raises Target Price to $60 From $30
TRAX•Related News
Enveric welcomes final FDA guidance on psychedelic drug trials
ENVB•
Vaxart names Kevin Finney, James Breitmeyer as board committee chairs
VXRT•
Authid Announces Expanded OEM Partnership With Majorkey Technologies
AUID•
Ecolab Q2 sales slightly beat estimates, lifts 2026 adjusted EPS outlook
ECL•
IDEX declares R$ 0.13 per unit distribution for 3Q 2026, payable July 30
IEX•